antithrombotic agent
Showing 1 - 25 of 6,559
Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation Trial in Copenhagen, Oslo, Umeå (Antithrombotic Agent)
Recruiting
- Cerebral Hemorrhage
- +4 more
- Antithrombotic Agent
-
Copenhagen, Denmark
- +2 more
Sep 7, 2021
Antiphospholipid Syndrome, Arterial Thrombosis Trial in Buenos Aires, Córdoba, Hamilton (Dual antiplatelet therapy, Combined
Recruiting
- Antiphospholipid Syndrome
- Arterial Thrombosis
- Dual antiplatelet therapy
- +3 more
-
Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
- +2 more
Dec 12, 2022
After PCI Coronary Intervention in Non-valvular Atrial
Unknown status
- Atrial Fibrillation
- +3 more
- Antithrombotic Agent
-
Milan, ItalyCosmo Godino
Mar 25, 2020
Safe and Timely Antithrombotic Removal (STAR) Registry
Recruiting
- Hemorrhage, Surgical
- +3 more
- CytoSorb
-
Vienna, Austria
- +11 more
Jan 17, 2023
Better antithrOmbotic Strategies in AF (RAINBOW-AF)
Not yet recruiting
- Atrial Fibrillation
- Anticoagulant Therapy
- (no location specified)
May 18, 2022
Bemiparine asProphylactic Antithrombotic Agent, in Patients
Completed
- Patients Undergoing Microvascular Surgery
-
Madrid, SpainRamon y Cajal Hospital
Feb 8, 2019
Platelet Membrane Cloaked Recombinant Staphylokinase on Human
Not yet recruiting
- Arterial Thrombosis
- collection of venous blood or arterial blood
- (no location specified)
Aug 6, 2023
Gastric Dysplasia, Gastric Cancer in Situ Trial in Hong Kong (Endoscopic closure of ESD defect, Gastric ESD without closure of
Recruiting
- Gastric Dysplasia
- Gastric Cancer in Situ
- Endoscopic closure of ESD defect
- Gastric ESD without closure of ESD defect
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Aug 2, 2021
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Dec 14, 2022
ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Recombinant Staphylokinase, Normal Saline)
Active, not recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Recombinant Staphylokinase
- Normal Saline
-
Nanjing, Jiangsu, China
- +7 more
Jan 30, 2023
Left Atrial Appendage Occlusion Trial in Barcelona (Apixaban vs. DAPT)
Completed
- Left Atrial Appendage Occlusion
- Apixaban vs. DAPT
-
Barcelona, SpainHospital Clinic Barcelona
Nov 21, 2022
Antithrombotic Agents Management Trial in Ioannina
Completed
- Antithrombotic Agents Management
-
Ioannina, GreeceUniversity Hospital of Ioannina
Feb 19, 2021
Coronary Artery Disease Trial in Seoul (Collastat, Floseal)
Completed
- Coronary Artery Disease
- Collastat
- Floseal
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University College of
Mar 6, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis Trial in Beijing (Drug-coated balloon (Bingo© [Paclitaxel-coated
Recruiting
- Drug-coated Balloon
- +2 more
- Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
- Drug-eluting stent
-
Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases，Chin
Oct 14, 2023
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Jun 30, 2022
Stroke, Acute Trial in Worldwide (Tenecteplase, Antiplatelet treatment)
Recruiting
- Stroke, Acute
- Tenecteplase
- Antiplatelet treatment
-
Canberra, Australian Capital Territory, Australia
- +60 more
May 16, 2022
Safety Outcome in Atrial Fibrillation Treated by Apixaban in
Recruiting
- Atrial Fibrillation
-
Brussels, BelgiumPfizer Site
Oct 10, 2022
Thromboembolic Complications in COVID-19 Intensive Care Unit
Active, not recruiting
- COVID-19-Associated Thromboembolism
-
Kocaeli, Derince, TurkeyDerince Research and Training Hospital
Sep 7, 2023
Acute Myocardial Infarction Trial in China (Recombinant Staphylokinase, normal saline)
Completed
- Acute Myocardial Infarction
- Recombinant Staphylokinase
- normal saline
-
Nanjing, Jiangsu, China
- +8 more
Jan 12, 2023
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023
Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent
Active, not recruiting
- Coronary Artery Disease
- Atheroscleroses, Coronary
- Antiplatelet Agents
- (no location specified)
Oct 1, 2022
